We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
BOI.PA

Price
23.50
Stock movement down
-0.40 (-1.67%)
Company name
Boiron SA
Exchange
(PA
,
Currency
EUR
)
Sector
Healthcare >
Drug Manufacturers - Specialty & Generic
Market cap
408.01M
Ent value
539.37M
Price/Sales
0.57
Price/Book
1.09
Div yield
-
Div growth
-
Growth years
-
FCF payout
466.37%
Trailing P/E
10.42
Forward P/E
13.76
PEG
-
EPS growth
-8.57%
1 year return
-30.27%
3 year return
-18.49%
5 year return
-6.54%
10 year return
-12.57%
Last updated: 2025-04-12

DIVIDENDS

BOI.PA does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E10.42
Price to OCF5.80
Price to FCF8.20
Price to EBITDA3.34
EV to EBITDA4.42

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales0.57
Price to Book1.09
EV to Sales0.75

FINANCIALS

Per share

Loading...
Per share data
Current share count17.36M
EPS (TTM)2.26
FCF per share (TTM)2.86

Income statement

Loading...
Income statement data
Revenue (TTM)721.60M
Gross profit (TTM)525.78M
Operating income (TTM)45.51M
Net income (TTM)39.16M
EPS (TTM)2.26
EPS (1y forward)1.71

Margins

Loading...
Margins data
Gross margin (TTM)72.86%
Operating margin (TTM)6.31%
Profit margin (TTM)5.43%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash53.33M
Net receivables77.70M
Total current assets255.65M
Goodwill89.70M
Intangible assets29.74M
Property, plant and equipment0.00
Total assets557.65M
Accounts payable37.20M
Short/Current long term debt14.85M
Total current liabilities113.86M
Total liabilities184.68M
Shareholder's equity372.97M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)70.39M
Capital expenditures (TTM)19.79M
Free cash flow (TTM)49.74M
Dividends paid (TTM)231.96M

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity10.50%
Return on Assets7.02%
Return on Invested Capital10.31%
Cash Return on Invested Capital13.09%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open24.10
Daily high24.10
Daily low23.50
Daily Volume1K
All-time high111.35
1y analyst estimate33.30
Beta0.45
EPS (TTM)2.26
Dividend per share-
Ex-div date3 Jun 2024
Next earnings date-

Downside potential

Loading...
Downside potential data
BOI.PAS&P500
Current price drop from All-time high-78.90%-12.89%
Highest price drop-78.90%-56.47%
Date of highest drop11 Apr 20259 Mar 2009
Avg drop from high-25.41%-11.07%
Avg time to new high39 days12 days
Max time to new high2564 days1805 days
COMPANY DETAILS
BOI.PA (Boiron SA) company logo
Marketcap
408.01M
Marketcap category
Small-cap
Description
Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products include medical devices, invitro diagnostics, dietary supplements, cosmetics, and phytotherapy. It also provides homeopathic specialties comprising Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for babies; Sédatif PC to treat anxiety and emotional, and minor sleep disorders; Coryzalia for the treatment of cold symptoms and rhinitis; Homéoptic to treat eye discomfort and irritation due to various causes for adults and children; Homéovox for vocal disorders; Homéoplasmine for treating irritated skin and redness; Varésol to treat symptoms of chickenpox; and Arnicare Arthritis for use in the treatment of benign trauma pain. In addition, it offers Dermoplasmine, a plant based multi-use balm that repairs and protects irritated and damaged skin; COVID self-tests and rapid antigenic tests; LABIAMEO, that used to treat outbreaks of localized cold sores; and CONVAMEO to treat physical and mental asthenia. The company offers its products through distribution centers, pharmacies, pharmacy chains, wholesalers, grocery and drugstores, health food stores, and online retail. Boiron SA was founded in 1932 and is headquartered in Messimy, France.
Employees
2788
Investor relations
-
CEO
Country
France
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
Polygon Labs CEO Marc Boiron says prediction markets like Polymarket offer faster and more accurate insights than traditional news, pointing to the 2024 U.S. elections as proof.
March 5, 2025
As European markets continue to rally, supported by slowing inflation and positive economic sentiment, investors are increasingly looking for stable opportunities amidst the broader market optimism. I...
September 6, 2024
The French stock market has recently shown resilience, with the CAC 40 Index advancing by 2.48% amid growing hopes for another round of interest rate cuts. As the Eurozone economy maintains its steady...
August 22, 2024
The French market has recently seen a significant decline, with the CAC 40 Index dropping 3.54% amid global concerns over weak U.S. economic data and broader growth worries. Despite this volatility, d...
August 7, 2024
As of July 2024, the French market, along with other European indices, has shown resilience with the CAC 40 Index experiencing a modest rise. This positive trajectory in Europe comes amidst a broader ...
July 18, 2024
Amid a backdrop of heightened political uncertainty and rising bond yields in France, investors are closely monitoring market dynamics as the country approaches a significant election. In such an envi...
July 3, 2024
Amidst the backdrop of political uncertainty and fluctuating bond yields in Europe, investors may find stability and potential income through dividend stocks. In this context, companies like Boiron on...
June 18, 2024
Amidst a backdrop of rising inflation and economic uncertainty across Europe, the French market has seen its share of fluctuations, with the CAC 40 Index recently experiencing a notable decline. In su...
June 3, 2024
Amid a backdrop of rising optimism in European markets, with France's CAC 40 Index experiencing a notable increase of 3.29%, investors continue to seek stable returns in an ever-evolving economic land...
May 17, 2024